Molecular mechanisms of cisplatin resistance

Galluzzi, L, Senovilla, L, Vitale, I, Michels, J, Martins, I, Kepp, O, Castedo, M, Kroemer, G·2012·Oncogene
DOI 10.1038/onc.2011.384

Cited by (1,001)

Items 901–1,000 of 1,001

  1. Cisplatin Resistance and Metabolism: Simplification of Complexity
    Nikolay V. Pervushin, Maria A. Yapryntseva, Mikhail Aleksandrovich Panteleev, Boris Zhivotovsky, Gelina S. Kopeina · 2024 · Cancers
  2. Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A
    Shinya Matsuzaki, Takayuki Enomoto, Satoshi Serada, Kiyoshi Yoshino, Shushi Nagamori, Akiko Morimoto, Takuhei Yokoyama, Ayako Kim, Toshihiro Kimura, Yutaka Ueda et al. · 2013 · International Journal of Cancer
  3. Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model
    Anne Jørgensen, Martin Blomberg Jensen, John E. Nielsen, Anders Juul, Ewa Rajpert‐De Meyts · 2012 · The Journal of Steroid Biochemistry and Molecular Biology
  4. Overexpression of CD 147 contributes to the chemoresistance of head and neck squamous cell carcinoma cells
    Zhiquan Huang, Lili Wang, Youyuan Wang, Ying Zhuo, Haigang Li, Ju Chen, Wei‐liang Chen · 2013 · Journal of Oral Pathology and Medicine
  5. siRNA-mediated knockdown of ID1 disrupts Nanog- and Oct-4-mediated cancer stem cell-likeness and resistance to chemotherapy in gastric cancer cells
    Linlin Li, Xiaoyong Wei, Baofeng Wu, Yuanli Xiao, Mingzhu Yin, Qiaohong Yang · 2017 · Oncology Letters
  6. A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells
    Weisha Liu, Shuyuan Wang, Shunheng Zhou, Feng Yang, Wei Jiang, Qingyuan Zhang, Lihong Wang · 2017 · Molecular BioSystems
  7. Musashi1 Promotes Non-Small Cell Lung Carcinoma Malignancy and Chemoresistance via Activating the Akt Signaling Pathway
    Yaoguo Lang, Xianglong Kong, Changjun He, Fengjiao Wang, Benkun Liu, Shibo Zhang, Jinfeng Ning, Kaibin Zhu, Shidong Xu · 2017 · Cellular Physiology and Biochemistry
  8. Role of Seroalbumin in the Cytotoxicity ofcis-Dichloro Pt(II) Complexes with (N^N)-Donor Ligands Bearing Functionalized Tails
    Cristina Pérez-Arnáiz, Jorge Leal, Natalia Busto, M. Carmen Carrión, Ana R. Rubio, Imanol Ortiz, Giampaolo Barone, Borja Díaz de Greñu, Javier Santolaya, José Maria Leal et al. · 2018 · Inorganic Chemistry
  9. ABT737 enhances ovarian cancer cells sensitivity to cisplatin through regulation of mitochondrial fission via Sirt3 activation
    Lin Hou, Ruobing Wang, Haifeng Wei, Shouqing Li, Lei Liu, Xiaodan Lü, Huimei Yu, Ziling Liu · 2019 · Life Sciences
  10. Exosome-mediated transfer of circ_0063526 enhances cisplatin resistance in gastric cancer cells via regulating miR-449a/SHMT2 axis
    Gang Yang, Jie Tan, Jian Guo, Zhiwei Wu, Qiong Zhan · 2022 · Anti-Cancer Drugs
  11. In vitro studies on the selective cytotoxic effect of luminescent Ru( ii )- p -cymene complexes of imidazo-pyridine and imidazo quinoline ligands
    Pravinkumar Selvam, Sourav De, Priyankar Paira, S.K. Ashok Kumar, Selva Kumar Ramasamy, Anbalagan Moorthy, Arjita Ghosh, Yung‐Chih Kuo, Subhasis Banerjee, Jenifer Shantha Kumar · 2022 · Dalton Transactions
  12. The efficacy of adjuvant immunochemotherapy with OK-432 after curative resection of gastric cancer: an individual patient data meta-analysis of randomized controlled trials
    Mari S. Oba, Satoshi Teramukai, Yasuo Ohashi, Kenji Ogawa, Yoshihiko Maehara, Junichi Sakamoto · 2015 · Gastric Cancer
  13. Celastrol induces proteasomal degradation of FANCD 2 to sensitize lung cancer cells to DNA crosslinking agents
    Guizhen Wang, Yongqiang Liu, Xin Cheng, Guang‐Biao Zhou · 2015 · Cancer Science
  14. Abrogation by Curcumin on Testicular Toxicity Induced by Cisplatin in Rats
    Ehab Tousson, Ezar Hafez, Ahmed Masoud, Aya A. Hassan · 2014 · The Journal of Cancer Research
  15. Interactions between Anticancer trans -Platinum Compounds and Proteins: Crystal Structures and ESI-MS Spectra of Two Protein Adducts of trans -(Dimethylamino)(methylamino)dichloridoplatinum(II)
    Luigi Messori A, Tiziano Marzo, Elena Michelucci, Irene Russo Krauss, Carmen Navarro‐Ranninger, Adoración G. Quiroga, Antonello Merlino · 2014 · Inorganic Chemistry
  16. Role of reactive oxygen species in p53 activation during cisplatin-induced apoptosis of rat mesangial cells.
    Ju Sm, Pae Ho, Kim Ws, D-G Kang, Lee Hs, Jeon Bh · 2014 · PubMed
  17. Potential Anticancer Properties and Mechanisms of Action of Withanolides
    Abbas K. Samadi · 2015 · The Enzymes
  18. NOX5-L can stimulate proliferation and apoptosis depending on its levels and cellular context, determining cancer cell susceptibility to cisplatin
    So Hee Dho, Ji Young Kim, Eun‐Soo Kwon, Jae Cheong Lim, Sung Sup Park, Ki‐Sun Kwon · 2015 · Oncotarget
  19. Rho inhibition by lovastatin affects apoptosis and DSB repair of primary human lung cells in vitro and lung tissue in vivo following fractionated irradiation
    Verena Ziegler, Christian Henninger, Ioannis Simiantonakis, Marcel Buchholzer, Mohammad Reza Ahmadian, Wilfried Budach, Gerhard Fritz · 2017 · Cell Death and Disease
  20. Epithelial–mesenchymal transition and cancer stem cells: A route to acquired cisplatin resistance through epigenetics in HNSCC
    Julia Lima de Oliveira, Thaís Moré Milan, Rayana Longo Bighetti‐Trevisan, Roger Rodrigo Fernandes, Andréia Machado Leopoldino, Luciana O. Almeida · 2022 · Oral Diseases
  21. Mitochondrial-Targeted Multifunctional Platinum-Based Nano “Terminal-Sensitive Projectile” for Enhanced Cancer Chemotherapy Efficacy
    Qiang Zhang, Jiamin Lin, Jun Li, Yitian Zhou, Bi ZhiQiang, Hao Yang, Wenli Lu, Tianming Lu, Ruoning Qian, Xi Yang et al. · 2025 · ACS Nano
  22. Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1
    Lei Duan, Ricardo E. Perez, Michael Hansen, Steven Gitelis, Carl G. Maki · 2014 · Cancer Biology & Therapy
  23. DESC1, a novel tumor suppressor, sensitizes cells to apoptosis by downregulating the EGFR/AKT pathway in esophageal squamous cell carcinoma
    Hoi Yan Ng, Josephine Mun Yee Ko, Valen Zhuoyou Yu, Joseph Chok Yan Ip, Wei Dai, Santiago Cal, Maria Li Lung · 2016 · International Journal of Cancer
  24. Knockdown of retinoblastoma protein may sensitize glioma cells to cisplatin through inhibition of autophagy
    Xiangyu Liu, Kangjian Sun, Handong Wang, Yuyuan Dai · 2016 · Neuroscience Letters
  25. DNA damaging agent-induced apoptosis is regulated by MCL-1 phosphorylation and degradation mediated by the Noxa/MCL-1/CDK2 complex
    Wataru Nakajima, Kanika Sharma, June Young Lee, Nicolas T. Maxim, Mark A. Hicks, Thien-Trang Vu, Angela Luu, William Andrew Yeudall, Nobuyuki Tanaka, Hisashi Harada · 2016 · Oncotarget
  26. MiRNAs-mediated cisplatin resistance in breast cancer
    Xiu Chen, Peng Lü, Ying Wu, Dandan Wang, Siying Zhou, Su‐Jin Yang, Hong-Yu Shen, Xiaohui Zhang, Jianhua Zhao, Jinhai Tang · 2016 · Tumor Biology
  27. ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer
    Eun Young Kim, Ji Ye Jung, Arum Kim, Yoon Soo Chang, Soon Il Kim · 2017 · Neoplasia
  28. Heparin antagonizes cisplatin resistance of A2780 ovarian cancer cells by affecting the Wnt signaling pathway
    Daniel Bastian Pfankuchen, Fabian Baltes, Tahira Batool, Jin‐Ping Li, Martin Schlesinger, Gerd Bendas · 2017 · Oncotarget
  29. Trial watch: DNA-based vaccines for oncological indications
    Stefano Pierini, Renzo F. Perales-Linares, Mireia Uribe‐Herranz, Jonathan G. Pol, Laurence Zitvogel, Guido Kroemer, Andrea Facciabene, Lorenzo Galluzzi · 2017 · OncoImmunology
  30. Downregulation of miR-503 contributes to the development of drug resistance in ovarian cancer by targeting PI3K p85
    Di Wu, Pan Lu, Xue Mi, Jinwei Miao · 2018 · Archives of Gynecology and Obstetrics
  31. mEAK-7 Forms an Alternative mTOR Complex with DNA-PKcs in Human Cancer
    Joe Truong Nguyen, Fatima Haidar, Alexandra Lucienne Fox, Connor Ray, Daniela Baccelli Silveira Mendonça, Jin Koo Kim, Paul H. Krebsbach · 2019 · iScience
  32. Long Non-Coding RNA in Drug Resistance of Non-Small Cell Lung Cancer: A Mini Review
    Ruizheng Sun, Ranran Wang, Siyuan Chang, Kexin Li, Rongsi Sun, Mengnan Wang, Zheng Li · 2019 · Frontiers in Pharmacology
  33. Non-coding RNAs in drug resistance of head and neck cancers: A review
    Fengsheng Dai, Li Dai, Xiwang Zheng, Yujia Guo, Yuliang Zhang, Min Niu, Yan Lü, Huizheng Li, Rui Hou, Yu Zhang et al. · 2020 · Biomedicine & Pharmacotherapy
  34. Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer
    María Elena Reyes, Marjorie De la Fuente, Marcela Alejandra Hermoso, Carmen Ili, Priscilla Brebi · 2020 · Frontiers in Immunology
  35. Exploration of Matrix Effects in Laser Ablation Inductively Coupled Plasma Mass Spectrometry Imaging of Cisplatin-Treated Tumors
    Calum J. Greenhalgh, Ellie Karekla, Gareth J. Miles, Ian R. Powley, Catia Costa, Janella de Jesus, Melanie Jane Bailey, Catrin A. Pritchard, Marion MacFarlane, J. Howard Pringle et al. · 2020 · Analytical Chemistry
  36. Inactivation of REV7 enhances chemosensitivity and overcomes acquired chemoresistance in testicular germ cell tumors
    Yasutaka Sakurai, Masaaki Ichinoe, Kazuki Yoshida, Yuka Nakazato, Shoji Saito, Masashi Satoh, Norihiro Nakada, Itaru Sanoyama, Atsuko Umezawa, Yoshiko Numata et al. · 2020 · Cancer Letters
  37. Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models
    Tristan Rupp, Océane Pelouin, Laurie Genest, Christophe Legrand, Guillaume Froget, Vincent Castagné · 2020 · Translational Oncology
  38. Non coding RNAs as the critical factors in chemo resistance of bladder tumor cells
    Amir Sadra Zangouei, Hamid Reza Rahimi, Majid Mojarrad, Meysam Moghbeli · 2020 · Diagnostic Pathology
  39. Profiling Cisplatin Resistance in Head and Neck Cancer: A Critical Role of the VRAC Ion Channel for Chemoresistance
    Svenja Siemer, Torsten Fauth, Paul Scholz, Yara Al-Zamel, Aya Khamis, Désirée Gül, Laura Freudelsperger, Barbara Wollenberg, Sven Becker, Roland H. Stauber et al. · 2021 · Cancers
  40. Vitamin B6 metabolism influences the intracellular accumulation of cisplatin
    Lorenzo Galluzzi, Sabrina Marsili, Ilio Vitale, Laura Senovilla, Judith Michels, Pauline Garcia, Erika Vacchelli, Étienne Chatelut, Maria Castedo, Guido Kroemer · 2013 · Cell Cycle
  41. Metabolomic Profiling of the Effects of Melittin on Cisplatin Resistant and Cisplatin Sensitive Ovarian Cancer Cells Using Mass Spectrometry and Biolog Microarray Technology
    Sanad Alonezi, Jonans Tusiimire, Jennifer Wallace, Mark J. Dufton, John A. Parkinson, Louise Young, Carol J. Clements, Jin Myung Park, Jong Jeon, Valerie Anne Ferro et al. · 2016 · Metabolites
  42. Dynasore suppresses proliferation and induces apoptosis of the non-small-cell lung cancer cell line A549
    Feifei Shen, Junda Gai, Jilin Xing, Jingqian Guan, Lin Fu, Qingchang Li · 2017 · Biochemical and Biophysical Research Communications
  43. Poly Organotin Acetates against DNA with Possible Implementation on Human Breast Cancer
    George K. Latsis, C.N. Banti, N. Kourkoumelis, Constantina Papatriantafyllopoulou, Nikos Panagiotou, Anastasios J. Tasiopoulos, Alexios P. Douvalis, Angelos G. Kalampounias, Thomas V. Bakas, S.K. Hadjikakou · 2018 · International Journal of Molecular Sciences
  44. Triggering TLR3 pathway promotes tumor growth and cisplatin resistance in head and neck cancer cells
    Hui‐Ching Chuang, Ming-Huei Chou, Chih‐Yen Chien, Jiin‐Haur Chuang, Yuli Liu · 2018 · Oral Oncology
  45. ADGRG1 Is a Predictor of Chemoresistance and Poor Survival in Cervical Squamous Carcinoma
    Shuo Zhang, Kui Guo, Ying Liang, Kun Wang, Shuyan Liu, Xingsheng Yang · 2021 · Frontiers in Oncology
  46. CaCO 3 nanoplatform for cancer treatment: drug delivery and combination therapy
    Xiaorong Yang, Yue Sun, Hong Zhang, Fengrui Liu, Qin Chen, Qiying Shen, Zhe Kong, Qiaolin Wei, Jia‐Wei Shen, Yong Guo · 2024 · Nanoscale
  47. STING pathway activation with cisplatin polyprodrug nanoparticles for chemo-immunotherapy in ovarian cancer
    Huijiao Fu, Xiaoqiao Guo, Fang Feng, Zhou Cao, Yuanyuan Chen, Xuanbo Zhang, Bingchen Zhang, Xinran Li, Qiwen Liu, Jie Liu et al. · 2025 · Journal of Controlled Release
  48. Mitochondrial Transcription Factor A and Mitochondrial Genome as Molecular Targets for Cisplatin-Based Cancer Chemotherapy
    Kimitoshi Kohno, Ke‐Yong Wang, Mayu Takahashi, Tomoko Kurita, Yoichiro Yoshida, Masakazu Hirakawa, Yoshikazu Harada, Akihiro Kuma, Hiroto Izumi, Shinji Matsumoto · 2015 · International Journal of Molecular Sciences
  49. Evaluation of novel trans-sulfonamide platinum complexes against tumor cell lines
    Carlos Pérez, C. Vanesa Díaz-García, Alba Agudo-López, Virginia del Solar, Silvia Cabrera, María Teresa Agulló-Ortuño, Carmen Navarro‐Ranninger, José Alemán, Jose Antonio Lopez-Martin · 2014 · European Journal of Medicinal Chemistry
  50. Phenotype plasticity rather than repopulation from CD90/CK14+ cancer stem cells leads to cisplatin resistance of urothelial carcinoma cell lines
    Margaretha A. Skowron, Günter Niegisch, Gerhard Fritz, Tanja Arent, Joep G.H. van Roermund, Andrea Romano, Peter Albers, Wolfgang A. Schulz, Michèle J. Hoffmann · 2015 · Journal of Experimental & Clinical Cancer Research
  51. xCT expression modulates cisplatin resistance in Tca8113 tongue carcinoma cells
    Peng Zhang, Wei Wang, ZHENHUI WEI, Xu Li, XUANNING YANG, Yuanhong Du · 2016 · Oncology Letters
  52. Nanomaterials as nanocarriers: a critical assessment why these are multi-chore vanquisher in breast cancer treatment
    Sania Naz, Hira Shahzad, Attarad Ali, Muhammad Zia · 2017 · Artificial Cells Nanomedicine and Biotechnology
  53. Silver Atomic Quantum Clusters of Three Atoms for Cancer Therapy: Targeting Chromatin Compaction to Increase the Therapeutic Index of Chemotherapy
    Vanesa Porto, Erea Borrajo, David Buceta, Carmen Carneiro, Shahana Huseyinova, Blanca Domínguez, Kyra J. E. Borgman, Melike Lakadamyali, M.F. Garcia Parajo, José Neissa et al. · 2018 · Advanced Materials
  54. Expression of Insulin-Like Growth Factor Binding Protein-5 (IGFBP5) Reverses Cisplatin-Resistance in Esophageal Carcinoma
    Dessy Chan, Yuanyuan Zhou, Chung Hin Chui, Kim Hung Lam, Simon Ying-Kit Law, Albert S. C. Chan, Xingshu Li, Alfred King-yin Lam, Johnny Cheuk On Tang · 2018 · Cells
  55. Induced cross-resistance of BRAFV600E melanoma cells to standard chemotherapeutic dacarbazine after chronic PLX4032 treatment
    Sarah Erdmann, Diana Seidel, Heinz‐Georg Jahnke, Marie Eichler, Jan‐Christoph Simon, Andrea Anneliese Robitzki · 2019 · Scientific Reports
  56. Aberrantly Expressed Timeless Regulates Cell Proliferation and Cisplatin Efficacy in Cervical Cancer
    Jinhua Zhou, Yinghui Zhang, Xinwei Zou, Lingling Kuai, Li Wang, Juan Wang, Fangrong Shen, Jinghui Hu, Xia Zhang, Yazhen Huang et al. · 2019 · Human Gene Therapy
  57. Histone Deacetylase Inhibitor Sensitizes ERCC1-High Non-small-Cell Lung Cancer Cells to Cisplatin via Regulating miR-149
    Yuwen He, Danyang Chen, Yanmei Yi, Shanshan Zeng, Shuang Liu, Pan Li, Hui Xie, P.Y. Yu, Guanmin Jiang, Hao Liu · 2020 · Molecular Therapy — Oncolytics
  58. Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy
    Chara Papadaki, Alexia A Monastirioti, Konstantinos Rounis, Dimitrios Makrakis, Konstantinos Kalbakis, Christoforos Nikolaou, Dimitrios Mavroudis, Sofia Agelaki · 2020 · Cancers
  59. Novel Application of Eupatilin for Effectively Attenuating Cisplatin‐Induced Auditory Hair Cell Death via Mitochondrial Apoptosis Pathway
    Xiaochan Lu, Tingting Deng, Hongsong Dong, Jinghong Han, Yanping Yu, Deng Xiang, Guohui Nie, Bing Hu · 2022 · Oxidative Medicine and Cellular Longevity
  60. The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
    Yu Wang, Zhao Huang, Bowen Li, Lin Liu, Canhua Huang · 2022 · Frontiers in Endocrinology
  61. Synthesis and characterization of polypyridine ruthenium(II) complexes and anticancer efficacy studies in vivo and in vitro
    Lijuan Liang, Xiaoyun Wu, Chuanling Shi, Haoyu Wen, Shouhai Wu, Jing Chen, Chunxia Huang, Yi Wang, Yunjun Liu · 2022 · Journal of Inorganic Biochemistry
  62. Growth differentiation factor 15 induces cisplatin resistance through upregulation of xCT expression and glutathione synthesis in gastric cancer
    Sheng‐Fan Wang, Yuh‐Lih Chang, Wen‐Liang Fang, Anna Fen–Yau Li, Chian‐Feng Chen, Tien‐Shun Yeh, Giun‐Yi Hung, Kuo‐Hung Huang, Hsin‐Chen Lee · 2023 · Cancer Science
  63. Proteomics of Genetically Engineered Mouse Mammary Tumors Identifies Fatty Acid Metabolism Members as Potential Predictive Markers for Cisplatin Resistance*
    M. Warmoes, J. Jaspers, Guotai Xu, Bharath Sampadi, T. Pham, J. Knol, S. Piersma, E. Boven, J. Jonkers, S. Rottenberg et al. · 2013 · Molecular & Cellular Proteomics
  64. Treatment With Anticancer Agents Induces Dysregulation of Specific Wnt Signaling Pathways in Human Ovarian Luteinized Granulosa Cells In Vitro
    Ana Maria Sanchez, Veronica Giorgione, Paola Viganò, Enrico Papaleo, Massimo Candiani, Giorgia Mangili, Paola Panina‐Bordignon · 2013 · Toxicological Sciences
  65. FTIR microspectroscopy defines early drug resistant human hepatocellular carcinoma (HepG2) cells
    Cholpajsorn Junhom, Natthida Weerapreeyakul, Waraporn Tanthanuch, Kanjana Thumanu · 2015 · Experimental Cell Research
  66. Role of isoenzyme M2 of pyruvate kinase in urothelial tumorigenesis
    Haiping Zhou, Xing Wang, Lan Mo, Yan Liu, Feng He, Fenglin Zhang, Kuo‐How Huang, Xue‐Ru Wu · 2016 · Oncotarget
  67. Facile synthesis of aquo-cisplatin arsenite multidrug nanocomposites for overcoming drug resistance and efficient combination therapy
    Jingyu Xin, Ke Zhang, Jiaqi Huang, Xiangjie Luo, Xuanqing Gong, Zhaoxuan Yang, Hongyu Lin, Hong Shan, Jinhao Gao · 2018 · Biomaterials Science
  68. Polyphyllin I and VII potentiate the chemosensitivity of A549/DDP cells to cisplatin by enhancing apoptosis, reversing EMT and suppressing the CIP2A/AKT/mTOR signaling axis
    Feifei Feng, Peng Cheng, Chaochao Wang, Yongbin Wang, Wei Wang · 2019 · Oncology Letters
  69. Tissue-specific expression of p73 C-terminal isoforms in mice
    Francesca Grespi, Ivano Amelio, Paola Tucci, Margherita Annicchiarico‐Petruzzelli, Gerry Melino · 2012 · Cell Cycle
  70. Immune checkpoint blockade therapy for bladder cancer treatment
    Jayoung Kim · 2016 · Korean journal of urology
  71. Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway
    Tao Li, Yujie Li · 2022 · Immunobiology
  72. Endoplasmic reticulum stress and quality control in relation to cisplatin resistance in tumor cells
    Wentao Mu, Yao Zhi, Jianpeng Zhou, Chuanlei Wang, Kaiyuan Chai, Zhongqi Fan, Guoyue Lv · 2024 · Frontiers in Pharmacology
  73. Developing a Palladium(II) Agent to Overcome Multidrug Resistance and Metastasis of Liver Tumor by Targeted Multiacting on Tumor Cell, Inactivating Cancer-Associated Fibroblast and Activating Immune Response
    Ming Jiang, Wenjuan Li, Jinzhe Liang, Min Pang, Shanhe Li, Gang Xu, Minghui Zhu, Hong Liang, Zhenlei Zhang, Feng Yang · 2024 · Journal of Medicinal Chemistry
  74. Novel platinum therapeutics induce rapid cancer cell death through triggering intracellular ROS storm
    Yongbin Liu, Dongfang Yu, Xueying Ge, Lingyi Huang, Ping‐Ying Pan, Haifa Shen, Roderic Ivan Pettigrew, Shu‐Hsia Chen, Junhua Mai · 2024 · Biomaterials
  75. REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells
    Wenjie Wang, Wenjiong Sheng, Chenxiao Yu, Jianping Cao, Jundong Zhou, Jinchang Wu, Huojun Zhang, Shuyu Zhang · 2015 · Oncology Reports
  76. Everolimus combined with cisplatin has a potential role in treatment of urothelial bladder cancer
    Rosário Pinto‐Leite, Regina Arantes‐Rodrigues, Carlos Palmeira, Bruno Colaço, Carlos Lopes, Aura Antunes Colaço, Céu Costa, Vítor Moreira Silva, Paula A. Oliveira, Lúcio Lara Santos · 2012 · Biomedicine & Pharmacotherapy
  77. Chemotherapy-induced dynamic gene expression changes in vivo are prognostic in ovarian cancer
    Antonis I. Koussounadis, Simon P. Langdon, David James Harrison, V. Anne Smith · 2014 · British Journal of Cancer
  78. PARP and other prospective targets for poisoning cancer cell metabolism
    Judith Michels, Florine Obrist, Maria Castedo, Ilio Vitale, Guido Kroemer · 2014 · Biochemical Pharmacology
  79. Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma.
    Te-Jen Su, Wen‐Hui Ku, Hsuan-Yu Chen, Yi Chiung Hsu, Qi-Sheng Hong, Gee Chen Chang, Sung‐Liang Yu, Jeremy J.W. Chen · 2016 · PubMed Central
  80. Evaluation of the cytotoxicity of the Bithionol - cisplatin combination in a panel of human ovarian cancer cell lines
    Vijayalakshmi N. Ayyagari, Tsung-han Jeff Hsieh, Paula Díaz‐Sylvester, Laurent Brard · 2017 · BMC Cancer
  81. Exploring the Influence of the Aromaticity on the Anticancer and Antivascular Activities of Organoplatinum(II) Complexes
    Ana Zamora, Sergio A. Pérez, Matthias Rothemund, Venancio Rodrı́guez, Rainer Schobert, Christoph Janiak, José Ruiz · 2017 · Chemistry - A European Journal
  82. ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis
    Yüksel Ürün, Jeffrey Jia Jun Leow, André Poisl Fay, Laurence K. Albiges, Toni K. Choueiri, Joaquim Bellmunt B · 2017 · Critical Reviews in Oncology/Hematology
  83. Homo- and heteroleptic Pt(II) complexes of ONN donor hydrazone and 4-picoline: A synthetic, structural and detailed mechanistic anticancer investigation
    Faiz‐Ur Rahman, Muhammad Zeeshan Bhatti, Amjad Ali, Hong‐Quan Duong, Yao Zhang, Bo Yang, Satish Koppireddi, Yue‐Jian Lin, Hui Wang, Zhan‐Ting Li et al. · 2017 · European Journal of Medicinal Chemistry
  84. Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation
    Anyue Wu, Liying Gu, Wei Cang, Mengxing Cheng, Wenjing Wang, Wen J. Di, Lei Haley Huang, Lihua Qiu · 2019 · Journal of Experimental & Clinical Cancer Research
  85. Molecular Characterization of Locally Relapsed Head and Neck Cancer after Concomitant Chemoradiotherapy
    Reinout H. de Roest, Steven W. Mes, Jos B. Poell, Arjen Brink, Mark A. van de Wiel, Elisabeth Bloemena, Elena Thai, Tito Poli, Charles René Leemans, Ruud H. Brakenhoff · 2019 · Clinical Cancer Research
  86. Synthesis, characterisation and potent cytotoxicity of unconventional platinum( iv ) complexes with modified lipophilicity
    Krishant M. Deo, Jennette A. Sakoff, Jayne Gilbert, Yingjie Zhang, Janice Rae Aldrich-Wright · 2019 · Dalton Transactions
  87. Inhibition of PI3K/AKT/mTOR and MAPK signaling pathways decreases progranulin expression in ovarian clear cell carcinoma (OCCC) cell line: a potential biomarker for therapy response to signaling pathway inhibitors
    Carlos Eduardo Perez-Juarez, Fabián Arechavaleta-Velasco, Moisés Zeferino-Toquero, Lourdes Álvarez‐Arellano, Isaías Estrada-Moscoso, Laura Dı́az-Cueto · 2019 · Medical Oncology
  88. Fanconi anemia-independent DNA inter-strand crosslink repair in eukaryotes
    Cody M. Rogers, Robert H. Simmons III, Gabriella E. Fluhler Thornburg, Nicholas J. Buehler, Matthew L. Bochman · 2020 · Progress in Biophysics and Molecular Biology
  89. Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma
    Sabrina Borchert, Pia-Maria Suckrau, Robert F. H. Walter, Michael Wessolly, Elena Mairinger, Julia Steinborn, Balázs Hegedűs, Thomas Hager, Thomas Herold, Wilfried Eberhardt et al. · 2020 · Scientific Reports
  90. Induction of NEDD8-conjugating enzyme E2 UBE2F by platinum protects lung cancer cells from apoptosis and confers to platinum-insensitivity
    Lisha Zhou, Jin Zhu, Wangyang Chen, Yanyu Jiang, Tao Hu, Yinxia Wang, Xiaoling Ye, Mengxi Zhan, Chenghao Ji, Zhuoming Xu et al. · 2020 · Cell Death and Disease
  91. Downregulation of Circ_0071589 Suppresses Cisplatin Resistance in Colorectal Cancer by Regulating the MiR-526b-3p/KLF12 Axis
    Weitong Zhang, Zhenfen Wang, Guohao Cai, Ping Cheong Huang · 2021 · Cancer Management and Research · Retracted
  92. Molecular markers of systemic therapy response in urothelial carcinoma
    Francesco Claps, Maria Carmen Mir, Homayoun S. Zargar · 2021 · Asian journal of urology
  93. PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study
    Fu-Shun Hsu, Wei‐Chou Lin, Kuan-Lin Kuo, Yen‐Ling Chiu, Chen-Hsun Hsu, Shih-Ming Liao, Jun-Ren Dong, Shing‐Hwa Liu, Shih-Chen Chang, Shao-Ping Yang et al. · 2021 · International Journal of Molecular Sciences
  94. eIF3a R803K mutation mediates chemotherapy resistance by inducing cellular senescence in small cell lung cancer
    Yixin Chen, Chenjing Wang, Desheng Xiao, Baimei He, Min Li, Xiaoping Yi, Wei Zhang, Ji‐Ye Yin, Zhaoqian Liu · 2021 · Pharmacological Research
  95. Fighting metallodrug resistance through alteration of drug metabolism and blockage of autophagic flux by mitochondria-targeting AIEgens
    Yan Su, Hai Lan Lin, Ying Tu, Mengmeng Wang, Guandong Zhang, Jin Yang, Hong‐Ke Liu, Zhi Su · 2022 · Chemical Science
  96. Inability of ovarian cancers to upregulate their MHC-class I surface expression marks their aggressiveness and increased susceptibility to NK cell-mediated cytotoxicity
    Nishant Chovatiya, Kawaljit Kaur, Sara Huerta‐Yépez, Po-Chun Chen, Adam S. Neal, Gabriella DiBernardo, Serhat Gumrukcu, Sanaz Memarzadeh, Anahid Jewett · 2022 · Cancer Immunology Immunotherapy
  97. Synthesis, X-ray crystal structure, DNA/BSA binding, DNA cleavage and cytotoxicity studies of phenanthroline based copper(II)/zinc(II) complexes
    Qingming Wang, Han Mao, Wenling Wang, Huimin Zhu, Lihui Dai, Yanli Chen, Xinhui Tang · 2017 · BioMetals
  98. Bidirect effects from cisplatin combine with rosmarinic acid (RA) or hot water extracts of Glechoma hederacea (HWG) on renal cancer cells
    Su‐Tze Chou, Bing‐Ying Ho, Yu‐Ting Tai, Chun‐Jen Huang, Wen‐Wan Chao · 2020 · Chinese Medicine
  99. Metabolic reprogramming by chemo-gene co-delivery nanoparticles for chemo-immunotherapy in head and neck squamous cell carcinoma
    Wenqing Zou, Bingyue Huo, Yaqin Tu, Yuhe Zhu, Yuwei Hu, Qianru Li, Xuan Yu, Bo Liu, Wei Tang, Songwei Tan et al. · 2025 · Acta Biomaterialia
  100. Recent advances in antitumor Pt(IV) complexes: Dual targeting and chemoimmunotherapy
    Daniil V. Spector, Anastasia Zharova, Vladislav Bykusov, Georgy L. Karetnikov, Elena Kimovna Beloglazkina, Olga Olegovna Krasnovskaya · 2025 · Coordination Chemistry Reviews